Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Antibiotic Selection00:57

Antibiotic Selection

52.1K
Overview
52.1K
Antimicrobial Proteins01:23

Antimicrobial Proteins

852
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
852
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

106
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
106
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epidemic features and potential impact of vaccine campaigns on the 2025 chikungunya outbreak in southern China: a mathematical modelling study.

New microbes and new infections·2026
Same author

Clinical Outcomes of Immunosuppressant drugs in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta Analysis.

Medical principles and practice : international journal of the Kuwait University, Health Science Centre·2026
Same author

The 2026 Ebola Outbreak and Mass Gathering Risk.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

<i>In vitro</i> activity of imipenem-relebactam against carbapenem-resistant <i>Pseudomonas aeruginosa</i>: correlation with carbapenem MICs and association with <i>β</i>-lactamase classes.

Frontiers in microbiology·2026
Same author

Hantavirus at the hajj: decoupling perceived risk from epidemiological reality.

Journal of travel medicine·2026
Same author

Elephant Rounds: a structured multi-disciplinary huddle to operationalise systems thinking in infection prevention and control.

The Journal of hospital infection·2026

相关实验视频

Updated: May 22, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

1.5K

新型抗生素针对的是格拉姆阴性细菌.

Jaffar A Al-Tawfiq1,2,3, Ranjit Sah4,5,6, Rachana Mehta7,8

  • 1Infectious Disease Unit, Specialty Internal Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Le infezioni in medicina
|March 12, 2025
PubMed
概括

新的抗生素正在开发中,以对抗抗菌素耐药性 (AMR),这是一个日益严重的全球健康危机. 然而,对于高优先级的耐药细菌,存在有限的选择,需要紧急的创新.

关键词:
抗生素 抗生素是一种抗生素.抗生素耐药性 抗生素耐药性多种药物耐药性的药物.新的抗生素 新的抗生素新型抗生素 新型抗生素管道管道管道管道管道管道

更多相关视频

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.1K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

相关实验视频

Last Updated: May 22, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

1.5K
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

10.1K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.1K

科学领域:

  • 微生物学 微生物学
  • 传染性疾病 传染性疾病
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁,增加死亡率和医疗保健成本.
  • 负责任的抗生素使用和新药开发是医疗保健专业人员对抗AMR的关键策略.

研究的目的:

  • 审查正在开发的新开发的抗生素.
  • 评估它们的发展状态,作用机制,活动范围和已批准的适用性.

主要方法:

  • 在Medline和ClinicalTrials.org的文献综述中,已批准的和管道中的抗生素处于第三阶段或新药申请 (NDA) 阶段.
  • 对第三阶段临床试验数据的分析.

主要成果:

  • 已经确定了几种新的抗生素,其中许多针对皮肤和肺炎等常见感染.
  • 观察到对高优先级耐药生物体的新药剂的有限可用性.
  • 大多数新的抗生素都是基于现有的分子或药剂.

结论:

  • 虽然新抗生素正在出现,但迫切需要对高优先级的耐药生物有效的药物,包括ESBL产生的肠杆菌,耐卡巴胺的肠杆菌,Acinetobacter baumannii和Pseudomonas aeruginosa.
  • 目前的发展重点是解决现有威胁,但对关键病原体的创新仍然不足.